Environmental factors associated with disease flare in juvenile and adult dermatomyositis

Rheumatology (United Kingdom)

Volumn 56, Issue 8, 2017, Pages 1342-1347

  Mamyrova, Gulnara ^a   Rider, Lisa G ^b   Ehrlich, Alison ^a   Jones, Olcay ^c   Pachman, Lauren M ^d   Nickeson, Robert ^e   Criscone Schreiber, Lisa G ^f   Jung, Lawrence K ^g   Miller, Frederick W ^b   Katz, James D ^a,h  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^h NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Dermatomyositis; Disease flare; Environmental factors; Juvenile dermatomyositis

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; MOOD STABILIZER; NONSTEROID ANTIINFLAMMATORY AGENT; WART VIRUS VACCINE; PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; ADULT DERMATOMYOSITIS; ADULT DISEASE; AGED; ARTICLE; CANADA; CHILD; CONTROLLED STUDY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENVIRONMENTAL FACTOR; EXERCISE; FATIGUE; FEMALE; FINANCIAL DEFICIT; GASTROENTERITIS; HEALTH SURVEY; HOUSING; HUMAN; INFANT; JUVENILE DERMATOMYOSITIS; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUSCLE WEAKNESS; NEWBORN; PRIORITY JOURNAL; RASH; SKIN PROTECTION; SUN EXPOSURE; SUNLIGHT PROTECTION; UNITED STATES; URINARY TRACT INFECTION; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; COMPLICATION; DISEASE COURSE; LIFE EVENT; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PRESCHOOL CHILD; QUESTIONNAIRE; STATISTICAL MODEL; SUNLIGHT; URINARY TRACT INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; CANADA; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; DISEASE PROGRESSION; FEMALE; GASTROENTERITIS; HUMANS; INFANT; LIFE CHANGE EVENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PSYCHOTROPIC DRUGS; SUNLIGHT; SURVEYS AND QUESTIONNAIRES; UNITED STATES; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 85028322888     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kex162     Document Type: Article

References (17)

1. Miller FW, Cooper RG, Vencovský J et al. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum 2013;65:3239-47.
2. Rider LG, Wu L, Mamyrova G, TargoffIN, Miller FW. Environmental factors preceding illness onset differ in phenotypes of the juvenile idiopathic inflammatory myopathies. Rheumatology 2010;49:2381-90.
3. Gourley M, Miller FW. Mechanisms of disease: environmental factors in the pathogenesis of rheumatic disease. Nat Clin Pract Rheumatol 2007;3:172-80.
4. Love LA, Weinberg CR, McConnaughey DR et al. Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women. Arthritis Rheum 2009;60:2499-504.
5. Shah M, TargoffIN, Rice MM, Miller FW, Rider LG. Ultraviolet radiation exposure is associated with clinical and autoantibody phenotypes in Juvenile Myositis. Arthritis Rheum 2013;65:1934-41.
6. Lyon MG, Bloch DA, Hollak B, Fries JF. Predisposing factors in polymyositis-dermatomyositis: results of a nationwide survey. J Rheumatol 1989;16:1218-24.
7. Orione MAM, Silva CA, Sallum AME et al. Exposure to tobacco and air pollutants during pregnancy. Arthritis Care Res 2014;66:1571-5.
8. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70.
9. Huber AM, Mamyrova G, Lachenbruch PA et al. Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res 2014;66:732-40.
10. Hasija R, Pistorio A, Ravelli A et al. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study. Arthritis Rheum 2011;63:3142-52.
11. Tan JA, Roberts-Thomson PJ, Blumbergs P et al. Incidence and prevalence of idiopathic inflammatory myopathies in South Australia: a 30-year epidemiologic study of histology-proven cases. Int J Rheum Dis 2013;16:331-8.
12. Fernandes EC, Silva CA, Braga ALF et al. Exposure to air pollutants and disease activity in juvenile-onset systemic lupus erythematosus patients. Arthritis Care Res 2015;67:1609-14.
13. De Waal AC, van Rossum MM, Kiemeney Lambertus ALM, Aben KKH. Reproducibility of self-reported melanoma risk factors in melanoma patients. Melanoma Res 2014;24:592-601.
14. Pachman LM, Lipton R, Ramsey-Goldman R et al. History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Arthritis Rheum 2005;53:166-72.
15. Gan L, Miller FW. State of the art: what we know about infectious agents and myositis. Curr Opin Rheumatol 2011;23:585-94.
16. Glatz M, Hofbauer GF. Phototoxic and photoallergic cutaneous drug reactions. Chem Immunol Allergy 2012;97:167-79.
17. Lupyan G. From chair to ''chair'': a representational shift account of object labeling effects on memory. J Exp Psychol Gen 2008;137:348-69.